Development of nintedanib nanosuspension for inhaled treatment of experimental silicosis

Silicosis is an irreversible and progressive fibrotic lung disease caused by massive inhalation of crystalline silica dust at workplaces, affecting millions of industrial workers worldwide. A tyrosine kinase inhibitor, nintedanib (NTB), has emerged as a potential silicosis treatment due to its inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade da Silva, Luisa Helena, Vieira, Juliana Borges, Cabral, Marianna Ribeiro, Antunes, Mariana Alves, Lee, Daiheon, Cruz, Fernanda Ferreira, Hanes, Justin, Rocco, Patricia Rieken Macedo, Morales, Marcelo Marcos, Suk, Jung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013831/
https://www.ncbi.nlm.nih.gov/pubmed/36925690
http://dx.doi.org/10.1002/btm2.10401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013831/
https://www.ncbi.nlm.nih.gov/pubmed/36925690
http://dx.doi.org/10.1002/btm2.10401

Ejemplares similares